Search Results - "Blanchard, Andrew P"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Substrate-Dependent Modulation of CYP3A4 Catalytic Activity: Analysis of 27 Test Compounds with Four Fluorometric Substrates by STRESSER, David M, BLANCHARD, Andrew P, TURNER, Stephanie D, ERVE, John C. L, DANDENEAU, Andre A, MILLER, Vaughn P, CRESPI, Charles L

    Published in Drug metabolism and disposition (01-12-2000)
    “…Inhibition of cytochrome P450 catalytic activity is a principal mechanism for pharmacokinetic drug-drug interactions. Rapid, in vitro testing for cytochrome…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Cytochrome P450 Fluorometric Substrates: Identification of Isoform-Selective Probes for Rat CYP2D2 and Human CYP3A4 by STRESSER, David M, TURNER, Stephanie D, BLANCHARD, Andrew P, MILLER, Vaughn P, CRESPI, Charles L

    Published in Drug metabolism and disposition (01-07-2002)
    “…We have tested a panel of 29 cDNA-expressed rat and human enzymes with 9 fluorometric substrates to determine the P450 isoform selectivity in the catalysis of…”
    Get full text
    Journal Article
  4. 4

    HUMAN CYTOCHROME P450 INDUCTION AND INHIBITION POTENTIAL OF CLEVIDIPINE AND ITS PRIMARY METABOLITE H152/81 by ZHANG, J. George, DEHAL, Shangara S, HO, Thuy, JOHNSON, Jennifer, CHANDLER, Catherine, BLANCHARD, Andrew P, CLARK, Robert J, CRESPI, Charles L, STRESSER, David M, WONG, James

    Published in Drug metabolism and disposition (01-05-2006)
    “…Clevidipine is a short-acting dihydropyridine calcium channel antagonist under development for treatment of perioperative hypertension. Patients treated with…”
    Get full text
    Journal Article
  5. 5

    Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole by Stresser, David M, Perloff, Elke S, Mason, Andrew K, Blanchard, Andrew P, Dehal, Shangara S, Creegan, Timothy P, Singh, Ritu, Gangl, Eric T

    Published in Drug metabolism and disposition (01-08-2016)
    “…The sedative clomethiazole (CMZ) has been used in Europe since the mid-1960s to treat insomnia and alcoholism. It has been previously demonstrated in clinical…”
    Get full text
    Journal Article
  6. 6

    Fluorometric High-Throughput Screening for Inhibitors of Cytochrome P450 by MILLER, VAUGHN P., STRESSER, DAVID M., BLANCHARD, ANDREW P., TURNER, STEPHANIE, CRESPI, CHARLES L.

    Published in Annals of the New York Academy of Sciences (01-09-2000)
    “…: Rapid screening for cytochrome P450 inhibitors is part of the current paradigm for avoiding development of drugs likely to give clinical pharmacokinetic…”
    Get full text
    Journal Article
  7. 7